Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-137

6 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 63323-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ble0a 0000 01)

Structure (Ble0a 0000 01)
Chemical structure of bleomycin sulfate, showing its detailed molecular formula with various rings, amino groups, and hydroxyl groups typical of this antibiotic compound used in chemotherapy.*
FDA Label Image

Fklogo (Ble0a 0000 02)

FDA Label Image

15-vial (Ble0a 0000 03)

15-vial (Ble0a 0000 03)
Label for Bleomycin injection, USP, 15 units per vial, lyophilized powder for reconstitution. Intended for intravenous, intramuscular, subcutaneous, or intrapleural use. Contains warnings about cytotoxicity and special handling procedures. Single dose vial, prescription only, labeled by Fresenius Kabi USA, LLC. Storage instructions specify to keep the powder under refrigeration (2° to 8°C, 36° to 46°F).*
FDA Label Image

15-ctn (Ble0a 0000 04)

15-ctn (Ble0a 0000 04)
Label for Bleomycin Injection, USP, 15 units per vial. The lyophilized powder is for intravenous, intramuscular, subcutaneous, or intrapleural use. The label notes the product is prescription only, single dose vial, with a caution for cytotoxicity and special handling procedures. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Vial (Ble0a 0000 05)

Vial (Ble0a 0000 05)
Bleomycin for Injection, USP, 30 units per vial, in a single dose vial for intravenous, intramuscular, subcutaneous, or intrapleural use. The label includes handling cautions for cytotoxic materials and storage instructions at 2°C to 8°C. The product is labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Carton (Ble0a 0000 06)

Carton (Ble0a 0000 06)
Bleomycin for Injection, USP 30 units per vial powder for solution. The label indicates usage routes including intravenous, intramuscular, subcutaneous, and intrapleural. Contains a caution about cytotoxicity and special handling procedures. The product is a single-dose vial labeled by Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.